ENTX
Entera Bio Ltd
2.90$
-0.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 69.2% | 86.4% | 93.5% | 93.4% | 93.6% | 93.7% | 97.5% | 97.9% | 95.7% | 95.5% | 44.4% | |
| 43.9% | 66.2% | 88.5% | 56.3% | 91.1% | 88.4% | 95.8% | 93.8% | 93.7% | 92.2% | 44.4% | |
| 43.9% | 66.2% | 88.5% | 86.4% | 91.1% | 88.4% | 95.8% | 93.8% | 93.7% | 92.2% | 44.4% | |
| – | – | – | 5.4% | 1.7% | 2.6% | 0.7% | 1.9% | 0.0% | 1.3% | 1.4% | |
| – | – | – | 1.0% | 0.5% | -1.0% | – | -2.2% | – | – | – | |
| 7.0% | 3.2% | 1.6% | 1.7% | 2.8% | 5.6% | 1.5% | 1.7% | – | – | – | |
| 23.8% | 10.4% | 4.9% | 4.9% | 3.6% | 6.2% | – | – | – | – | – | |
| 1,035.1% | 501.6% | 337.7% | 24.2% | 28.6% | 22.8% | 13.2% | 10.5% | 11.7% | 14.0% | 18.1% | |
| 29.3% | 167.7% | 15.2% | 13.4% | 27.5% | 18.9% | 12.2% | 10.2% | 9.3% | 12.5% | 13.8% | |
| 768.7% | 157.3% | 281.3% | – | 1.1% | 1.9% | 0.7% | 0.7% | 1.1% | 1.8% | 1.4% | |
| 12.8% | 0.8% | 4.5% | 3.5% | 2.0% | 1.7% | 0.6% | 0.1% | 0.7% | 1.4% | 2.8% | |
| 768.7% | 76.9% | 29.3% | – | – | – | – | – | – | – | – | |
| -935.1% | -401.6% | -237.7% | 75.8% | 71.4% | 77.2% | 86.8% | 89.5% | 88.3% | 86.0% | 81.9% | |
| -1,070.9% | -487.1% | -314.9% | -390.7% | -376.7% | -722.5% | -317.2% | -727.5% | -887.3% | -1,213.3% | -783.9% | |
| 433.1% | 189.3% | 89.6% | 86.3% | 72.7% | 189.4% | 100.6% | 219.5% | 246.6% | 401.0% | 288.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.